Shopping Cart
- Remove All
Your shopping cart is currently empty
Vandortuzumab is a humanised monoclonal antibody targeting STEAP1, commonly used as the targeting component of the synthetic ADC (antibody-drug conjugate) vandortuzumab vedotin, and is applicable for prostate cancer research.
| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $247 | In Stock | |
| 5 mg | $745 | In Stock | |
| 10 mg | $1,180 | In Stock | |
| 25 mg | $1,770 | In Stock | |
| 50 mg | $2,380 | In Stock |
| Description | Vandortuzumab is a humanised monoclonal antibody targeting STEAP1, commonly used as the targeting component of the synthetic ADC (antibody-drug conjugate) vandortuzumab vedotin, and is applicable for prostate cancer research. |
| Molecular Weight | 145.5 kDa |
| Storage | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.